MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/archsurg.143.7.679

Медицинская библиотека · Archives of surgery (Chicago, Ill. : 1960) · 2008

Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.

Doyle M B Majella, Anderson Christopher D, Vachharajani Neeta, Lowell Jeffrey A, Shenoy Surendra, Lisker-Melman Mauricio, Korenblat Kevin, Crippin Jeffrey S, Chapman William C

СтатьяПеревод в очереди

Аннотация

HYPOTHESIS: Older donor grafts will provide suitable results of liver transplant, even in recipients with hepatitis C virus (HCV). Although HCV remains the leading indication for liver transplant in adults in the United States, it is associated with HCV recurrence, increased graft loss, and reduced survival. In addition, recent studies suggest that the use of older donors in recipients with HCV is associated with significantly worsened short- and long-term survival.

DESIGN

Prospective database analysis.

SETTING

Washington University School of Medicine.

PATIENTS: Between January 1, 1997, and June 30, 2006, a total of 579 liver transplants were performed. Ninety pediatric transplants were excluded. Of the remaining 489 adult patients (84.5%), 187 (38.2%) had HCV and 302 (61.8%) had other indications.

MAIN OUTCOME MEASURES: Patient and graft survival, recurrence of HCV, and need for and results of retransplant.

RESULTS

At 1, 3, and 5 years, overall patient survival was 88.1%, 78.3%, and 69.2%, respectively, and graft survival was 85.6%, 75.6%, and 65.6%, respectively, in patients with HCV. There was no significant difference in patient or graft survival between patients with and those without HCV. Recurrent HCV with clinically significant disease was 20% at 1 year and 62% at 10 years. Seventy-two patients received transplants from donors 60 years or older (24 of 187 [12.8%] with HCV and 48 of 302 [15.9%] without HCV). No difference was demonstrated in short- or medium-term patient or graft survival in recipients of grafts from older donors.

CONCLUSION

The increasing use of marginal donors, including carefully selected older donors, does not seem to adversely affect short- or medium-term results and may be a source of additional organs for expanding liver transplant waiting lists.

Для цитирования: Doyle M B Majella, Anderson Christopher D, Vachharajani Neeta, Lowell Jeffrey A, Shenoy Surendra, Lisker-Melman Mauricio, Korenblat Kevin, Crippin Jeffrey S, Chapman William C. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.. Archives of surgery (Chicago, Ill. : 1960). 2008. DOI: 10.1001/archsurg.143.7.679.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.